At Vectura Fertin Pharma Laboratories (VFPL), we have more than 14 years of nonclinical research experience with specialized expertise in inhalation toxicology and areosol sciences. Learn more about our diverse range of highly customizable nonclinical toxicology services to support you in accelerating your drug into market.
GLP inhalation toxicology studies are at the core of our expertise.
Our studies are conducted in accordance to GLP standards and internationally accepted guidelines.
Vectura Fertin Pharma Laboratories has established and validated assays for in vitro safety assessment of novel chemical entities or biologics.
Our range of in vivo disease models include emphysema, chronic obstructive pulmonary disease (COPD), cardiovascular disease, cough, pulmonary fibrosis, etc.
Our agility in providing end-to-end laboratory solutions also means that Vectura Fertin Pharma Laboratories can be your partner at any point of your preclinical journey through our a la carte services.
Supporting Your Nonclinical Program From Early Development To Market